Evidence map›Paper›PMID 31729407›Full record

ArticleScientific reports2019

Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients.

Alexa M G A Laheij, Judith E Raber-Durlacher, Renée G A Koppelmans, Marie-Charlotte D N J M Huysmans, Carin Potting, Stephanie J M van Leeuwen, Mette D Hazenberg, Michael T Brennan, Inger von Bültzingslöwen, Jan-Erik Johansson and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Alexa M G A LaheijDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. a.laheij@acta.nl.ORCID http://orcid.org/0000-0003-1291-2798
Judith E Raber-DurlacherDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Renée G A KoppelmansDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Marie-Charlotte D N J M HuysmansDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Carin PottingDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Stephanie J M van LeeuwenDepartment of Dentistry, Radboud University Medical Center, Nijmegen, The Netherlands.
Mette D HazenbergDepartment of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Michael T BrennanDepartment of Oral Medicine, Carolinas Medical Center, Charlotte, NC, United States of America.
Inger von BültzingslöwenDepartment of Oral Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden.
Jan-Erik JohanssonDepartment of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden.
Johannes J de SoetDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Thijs M HavermanDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Mark J BuijsDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Bernd W BrandtDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Frederik R RozemaDepartment of Oral Medicine, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-8196-8811
Nicole M A BlijlevensDepartment of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Egija ZauraDepartment of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-1432-6194
Academic Center for Dentistry Amsterdam · NLRadboud University Nijmegen · NLAmsterdam University Medical Centers · NLCarolinas Medical Center · USSahlgrenska University Hospital · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this prospective, two center study was to investigate the dynamics of the microbial changes in relation to the development of ulcerative oral mucositis in autologous SCT (autoSCT) recipients. Fifty-one patients were diagnosed with multiple myeloma and treated with high-dose melphalan followed by autoSCT. They were evaluated before, three times weekly during hospitalization, and three months after autoSCT. At each time point an oral rinse was collected and the presence or absence of ulcerative oral mucositis (UOM) was scored (WHO scale). Oral microbiome was determined by using 16S rRNA amplicon sequencing and fungal load by qPCR. Twenty patients (39%) developed UOM. The oral microbiome changed significantly after autoSCT and returned to pre-autoSCT composition after three months. However, changes in microbial diversity and similarity were more pronounced and rapid in patients who developed UOM compared to patients who did not. Already before autoSCT, different taxa discriminated between the 2 groups, suggesting microbially-driven risk factors. Samples with high fungal load (>0.1%) had a significantly different microbial profile from samples without fungi. In conclusion, autoSCT induced significant and reversible changes in the oral microbiome, while patients who did not develop ulcerative oral mucositis had a more resilient microbial ecosystem.

Indexed as

DysbiosisMicrobiotaAgedBacteriaDisease SusceptibilityFemaleFungiHematopoietic Stem Cell TransplantationHumansMaleMetagenomeMetagenomicsMiddle AgedRNA, Ribosomal, 16SStomatitisTransplantation, AutologousRNA, Ribosomal, 16S

Identifiers

PMID31729407
PMCPMC6858439
OpenAlexW2983501965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.